LMAXLKLPSSIADV-IADCTJSHSA-N
C30H28F4N6O3S2 — CID 142455774
Data last refreshed: (MolForge compound catalog, from PubChem)
About LMAXLKLPSSIADV-IADCTJSHSA-N
LMAXLKLPSSIADV-IADCTJSHSA-N (PubChem CID 142455774) has the molecular formula C30H28F4N6O3S2 and a molecular weight of 660.72 g/mol. Its IUPAC name is N-[(4aS,6S)-1-(4-fluorophenyl)-4a-[5-(trifluoromethyl)-1,3-thiazole-2-carbonyl]-5,6,7,8-tetrahydro-4H-benzo[f]indazol-6-yl]-N-(cyclopropylmethyl)-1-methylimidazole-4-sulfonamide.
Molecular Properties
| Compound Name | LMAXLKLPSSIADV-IADCTJSHSA-N |
|---|---|
| PubChem CID | 142455774 |
| Molecular Formula | C30H28F4N6O3S2 |
| Molecular Weight | 660.72 g/mol |
| Exact Mass | 660.16 |
| IUPAC Name | N-[(4aS,6S)-1-(4-fluorophenyl)-4a-[5-(trifluoromethyl)-1,3-thiazole-2-carbonyl]-5,6,7,8-tetrahydro-4H-benzo[f]indazol-6-yl]-N-(cyclopropylmethyl)-1-methylimidazole-4-sulfonamide |
| SMILES | Cn1cnc(S(=O)(=O)N(CC2CC2)[C@H]2CCC3=Cc4c(cnn4-c4ccc(F)cc4)C[C@]3(C(=O)c3ncc(C(F)(F)F)s3)C2)c1 |
| InChI | InChI=1S/C30H28F4N6O3S2/c1-38-16-26(36-17-38)45(42,43)39(15-18-2-3-18)23-7-4-20-10-24-19(13-37-40(24)22-8-5-21(31)6-9-22)11-29(20,12-23)27(41)28-35-14-25(44-28)30(32,33)34/h5-6,8-10,13-14,16-18,23H,2-4,7,11-12,15H2,1H3/t23-,29-/m0/s1 |
| InChIKey | LMAXLKLPSSIADV-IADCTJSHSA-N |
| XLogP | 5.68 |
| TPSA | 102.98 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 660.72 |
| LogP ≤ 5 | 5.68 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142455774 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.